The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults
By J. Clark. Journal of Clinical Gastroenterology, 2006
805 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery
View Paper: https://www.semanticscholar.org/paper/6d48c43353586ac63ab0110226c6f7039223a6e5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Shih-Jen Hwang
- Elizabeth K. Speliotes
- U. Hoffmann
- B. Voight
- L. Yerges-Armstrong
- V. Gudnason
- G. Eiriksdottir
- M. Nalls
Citations in the corpus
- Hypertriglyceridemia: its etiology, effects and treatment (2007, background): “Among affected patients, up to one-third may also have nonalcoholic steatotic hepatitis.(13,14) Lipotoxicity, oxidative stress, cytokines and proinflammatory mediators contribute to the progression from steatosis to nonalcoholic steatotic hepatitis.”
- Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits (2011, background): “NAFLD includes a spectrum of disease ranging from fatty infiltration of the liver (steatosis) to histologic evidence of inflammation (nonalcoholic steatohepatitis or NASH), to fibrosis or cirrhosis, without a history of excessive alcohol ingestion [1,2].”